We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
AUM
$344M
AUM Growth
+$14.9M
Cap. Flow
+$4.56M
Cap. Flow %
1.32%
Top 10 Hldgs %
57.6%
Holding
101
New
11
Increased
48
Reduced
15
Closed
4

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.2M
2
XOM icon
ExxonMobil
XOM
+$1.76M
3
GILD icon
Gilead Sciences
GILD
+$1.45M
4
KEYS icon
Keysight
KEYS
+$1.22M
5
AGN
Allergan plc
AGN
+$683K

Sector Composition

Rank Sector Weight
1 Healthcare 36.49%
2 Industrials 17.6%
3 Technology 12.63%
4 Energy 11.69%
5 Financials 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
1
Merck
MRK
$307B
$55.7M 16.19%
695,882
-7,336
-1% -$562K
UNP icon
2
Union Pacific
UNP
$176B
$26.2M 7.62%
155,000
XOM icon
3
ExxonMobil
XOM
$615B
$22M 6.4%
287,296
-22,700
-7% -$1.76M
ROP icon
4
Roper Technologies
ROP
$36.6B
$16.9M 4.92%
46,201
+529
+1% +$188K
TMO icon
5
Thermo Fisher Scientific
TMO
$196B
$16.6M 4.83%
56,619
+861
+2% +$237K
AME icon
6
Ametek
AME
$53.9B
$13.5M 3.92%
148,412
+1,560
+1% +$134K
JPM icon
7
JPMorgan Chase
JPM
$901B
$12.8M 3.72%
114,541
+2,850
+3% +$314K
MUR icon
8
Murphy Oil
MUR
$5.28B
$12.4M 3.62%
504,855
-3,000
-0.6% -$79.2K
MSFT icon
9
Microsoft
MSFT
$2.99T
$11.1M 3.24%
83,136
+3,884
+5% +$493K
CELG
10
DELISTED
Celgene Corp
CELG
$10.8M 3.14%
116,666
-23,115
-17% -$2.2M
AMT icon
11
American Tower
AMT
$77.8B
$8.18M 2.38%
40,000
TECH icon
12
Bio-Techne
TECH
$11.2B
$6.66M 1.94%
127,728
+5,700
+5% +$287K
PCH
13
DELISTED
PotlatchDeltic
PCH
$5.91M 1.72%
151,661
PH icon
14
Parker-Hannifin
PH
$120B
$5.61M 1.63%
33,015
+2
+0% +$345
COO icon
15
Cooper Companies
COO
$14B
$5.39M 1.57%
64,000
GPN icon
16
Global Payments
GPN
$22.5B
$4.73M 1.38%
29,543
-12
-0% -$1.78K
AMZN icon
17
Amazon
AMZN
$2.69T
$4.63M 1.35%
48,900
+4,420
+10% +$412K
IDXX icon
18
Idexx Laboratories
IDXX
$44.5B
$4.57M 1.33%
16,588
+3
+0% +$739
MUSA icon
19
Murphy USA
MUSA
$11.5B
$3.65M 1.06%
43,413
GH icon
20
Guardant Health
GH
$19.6B
$3.63M 1.05%
42,006
+1,851
+5% +$141K
AAPL icon
21
Apple
AAPL
$4.8T
$3.61M 1.05%
72,956
-3,632
-5% -$177K
BA icon
22
Boeing
BA
$165B
$3.56M 1.03%
9,767
+271
+3% +$98.8K
V icon
23
Visa
V
$686B
$3.4M 0.99%
19,596
+2,072
+12% +$339K
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$4.3T
$3.23M 0.94%
59,560
+6,660
+13% +$386K
EOG icon
25
EOG Resources
EOG
$75.1B
$2.8M 0.82%
30,106
+1,316
+5% +$122K

Similar funds

Aristotle Atlantic Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Aristotle Atlantic Partners held 101 positions worth $344M, up 4.5% from $329M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Aristotle Atlantic Partners's Q2 2019 filing shows 11 new, 48 increased, 15 reduced and 4 closed positions. Its largest new stake was Illumina: 5,785 shares worth $2.07M. The largest sale was Celgene Corp, an estimated $2.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 37% a quarter earlier, followed by Industrials and Technology.

  • Aristotle Atlantic Partners's largest Q2 2019 buy was Illumina: 5,785 shares worth $2.07M.
  • Aristotle Atlantic Partners added most to Microsoft in Q2 2019, an estimated $493K increase.
  • Aristotle Atlantic Partners's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $2.2M.
  • Aristotle Atlantic Partners fully exited Keysight in Q2 2019, selling an estimated $1.22M.
  • Aristotle Atlantic Partners's ten largest holdings make up 58% of its $344M portfolio in Q2 2019.
  • Aristotle Atlantic Partners opened 11 new positions and closed 4 in Q2 2019.
  • Aristotle Atlantic Partners's portfolio value rose 4.5% quarter-over-quarter to $344M.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2019, filed 13 Aug 2019.